Exercise therapy has no effect on inflammatory marker levels in patients with or at risk of knee OA .
Impact of Exercise Therapy on Molecular Biomarkers Related to Cartilage and Inflammation in Individuals at Risk of, or With Established, Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Arthritis Care Res (Hoboken).2019. Nov;71(11):1504-1515. doi: 10.1002/acr.23786.The benefits of exercise are wide-ranging and well-documented. In the context of knee osteoarthritis, however, there is debate about the benefits of exercise therapy. While exercise therapy is sure to be beneficial to the patient's overall health and metabolic profile, it is less clear whether exercise - especially weight-bearing exercise - improves or worsens disease in patients with or at risk of osteoarthritis (OA). In this meta-analysis of randomized controlled trials, the authors assess whether exercise therapy, compared to non-exercise controls, had an impact on the biochemical markers of inflammation in patients with or at risk of knee OA. They found that among 9 biomarkers including C-reactive protein, Tumour Necrosis Factor (TNF-alpha), and interleukin-6 (IL-6), none of the biomarkers were significantly raised or lower due to exercise therapy. Overall, there is no evidence that exercise significantly increases or decreases inflammation, at least based on surrogate outcomes.
Vollständigen ACE-Bericht freischalten
Sie haben Zugang zu 4 weiteren KOSTENLOSEN Artikeln in diesem Monat.
Klicken Sie unten, um diese ACE Reports freizuschalten und anzusehen
Jetzt freischalten
Kritische Beurteilungen der neuesten, hochwirksamen randomisierten kontrollierten Studien und systematischen Übersichten in der Orthopädie
Zugang zu OrthoEvidence-Podcast-Inhalten, einschließlich Kooperationen mit dem Journal of Bone and Joint Surgery, Interviews mit international anerkannten Chirurgen und Diskussionsrunden zu orthopädischen Neuigkeiten und Themen
Abonnement von The Pulse, einem zweimal wöchentlich erscheinenden evidenzbasierten Newsletter, der Ihnen helfen soll, bessere klinische Entscheidungen zu treffen
Exklusiver Zugang zu Originalartikeln, einschließlich eigener systematischer Übersichten, sowie zu Artikeln über Methoden der Gesundheitsforschung und aktuelle orthopädische Themen